Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC) Meeting Abstract
| Authors: | Shah, M.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Leboulleux, S.; Godbert, Y.; Meurer, M.; Morris, J.; Owonikoko, T.; Tan, D. S. W.; Gautschi, O.; Patel, J.; Yang, L.; Kherani, J.; Cabanillas, M.; Wirth, L.; Weiler, D. |
| Abstract Title: | Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC) |
| Meeting Title: | 2020 Swiss Oncology and Hematology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 150 |
| Issue: | Suppl. 247 |
| Meeting Dates: | 2020 Nov 18-21 |
| Meeting Location: | Virtual |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2020-11-17 |
| Start Page: | 7 S |
| End Page: | 8 S |
| Language: | English |
| ACCESSION: | WOS:000592781900013 |
| PROVIDER: | wos |
| PUBMED: | 33200807 |
| DOI: | 10.4414/smw.2020.20411 |
| Notes: | Meeting Abstract: O12 -- Source: Wos |
